Phase 1 Immunoglobulin A Nephropathy Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
Immunoglobulin A Nephropathy
Beijing Mabworks Biotech Co., Ltd.130 enrolled1 locationNCT07375758
Completed
Phase 1
VIS649-102: A study assessing single doses of VIS649, in healthy adults.
Immunoglobulin A Nephropathy
IQVIA RDS Pty Limited48 enrolled1 locationACTRN12620001352998